The potential of phages to prevent MRSA infections

Research in Microbiology

Volumn 159, Issue 5, 2008, Pages 400-405

  Mann, Nicholas H ^a  

^a Barclays   (United Kingdom)

Author keywords

Biofilm; MRSA; Nosocomial infection; Phage therapy; Staphylococcus aureus

Indexed keywords

ANTIBIOTIC AGENT; PSEUDOMONIC ACID;

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIOPHAGE; CLOSTRIDIUM DIFFICILE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; VIRULENCE;

ANIMALS; BACTERIOPHAGES; HUMANS; METHICILLIN RESISTANCE; NOSE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

ANIMALIA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 49149089239     PISSN: 09232508     EISSN: 17697123     Source Type: Journal    
DOI: 10.1016/j.resmic.2008.04.003     Document Type: Article

References (42)

1. Bishop E.J., and Howden B.P. Treatment of Staphylococcus aureus infections: new issues, emerging therapies and future directions. Expert Opin. Emerg. Drugs 12 (2007) 1-22
2. Blok H.E.M., Troelstra A., Kamp-Hopmans T.E.M., Gigengack-Baars A.C.M., Vandenbroucke-Grauls C., Weersink A.J.L., et al. Role of healthcare workers in outbreaks of methicillin-resistant Staphylococcus aureus: a 10-year evaluation from a Dutch University Hospital. Infect. Control Hosp. Epidemiol. 24 (2003) 679-685
3. Bradley S.F. Eradication or decolonisation of methicillin-resistant Staphylococcus aureus carriage: what are we doing and why are we doing it?. Clin. Infect. Dis. 44 (2007) 186-189
4. Bruynoghe R., and Maisin J. Essais de thérapeutique au moyen du bactériophage. Compt. Rend. Soc. Biol. 85 (1921) 1120-1121
5. Burden, F.A. (2005) The ecology of temperate bacteriophages of the staphylococci and an evaluation of their potential as therapeutic agents. PhD thesis, University of Warwick.
6. Capparelli R., Parlato M., Borriello G., Salvatore P., and Iannelli D. Experimental phage therapy against Staphylococcus aureus in mice. Antimicrob. Agents Chemother. 51 (2007) 2765-2773
7. Cerca N., Oliveira R., and Azeredo J. Susceptibility of Staphylococcus epidermidis planktonic cells and biofilms to the lytic action of staphylococcus bacteriophage K. Lett. Appl. Microbiol. 45 (2007) 313-317
8. Chambers H.F. The changing epidemiology of Staphylococcus aureus?. Emerg. Infect. Dis. 7 (2001) 178-182
9. Critchley I.A. Eradication of MRSA nasal colonisation as a strategy for infection prevention. Drug Discov. Today: Ther. Strat. 3 (2006) 189-195
10. Deurenberg R.H., Vink C., Kalenic S., Friedrich A.W., Bruggeman C.A., and Stobberingh E.E. The molecular evolution of methicillin-resistant Staphylococcus aureus. Clin. Microbiol. Infect. 13 (2007) 222-235
11. Garcia P., Madera C., Martinez B., and Rodriguez A. Biocontrol of Staphylococcus aureus in curd manufacturing processes using bacteriophages. Int. Dairy J. 17 (2007) 1232-1239
12. Gill J.J., Pacan J.C., Carson M.E., Leslie K.E., Griffiths M.W., and Sabour P.M. Efficacy and pharmacokinetics of bacteriophage therapy in treatment of subclinical Staphylococcus aureus mastitis in lactating dairy cattle. Antimicrob. Agents Chemother. 50 (2006) 2912-2918
13. Gill J.J., Sabour P.M., Leslie K.E., and Griffiths M.W. Bovine whey proteins inhibit the interaction of Staphylococcus aureus and bacteriophage K.J. Appl. Microbiol. 101 (2006) 377-386
14. Goerke C., Wirtz C., Fluckiger U., and Wolz C. Extensive phage dynamics in Staphylococcus aureus contributes to adaptation to the human host during infection. Mol. Microbiol. 61 (2006) 1673-1685
15. Górski A., Borysowski J., Mie{ogonek}dzybrodzki R., and Weber-Da{ogonek}browska B. Bacteriophages in medicine. In: McGrath S., and van Sinderen D. (Eds). Bacteriophage: genetics and molecular biology (2007), Caister Academic Press, Norfolk 125-158
16. Götz F. Staphylococcus and biofilms. Mol. Microbiol. 43 (2002) 1367-1378
17. Grundmann H., Aires-De-Sousa M., Boyce J., and Tiemersma E. Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet 368 (2006) 874-885
18. Häusler T. Viruses vs. superbugs: a solution to the antibiotic crisis? (2006), Palgrave Macmillan, London
19. Jin T., Bokarewa M., McIntyre L., Tarkowski A., Corey G.R., Reller L.B., et al. Fatal outcome of bacteraemic patients caused by infection with staphylokinase-deficient Staphylococcus aureus strains. J. Med. Microbiol. 52 (2003) 919-923
20. Kluytmans J., vanBelkum A., and Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin. Microbiol. Rev. 10 (1997) 505-520
21. Kluytmans J., and Wertheim H.F.L. Nasal carriage of Staphylococcus aureus and prevention of nosocomial infections. Infection 33 (2005) 3-8
22. Laupland K.B., and Conly J.M. Treatment of Staphylococcus aureus colonisation and prophylaxis for infection with topical intranasal mupirocin: an evidence-based review. Clin. Infect. Dis. 37 (2003) 933-938
23. Levy S.B., and Marshall B. Antibacterial resistance worldwide: causes, challenges and responses. Nat. Med. 10 (2004) 122-S129
24. Loveday H.P., Pellowe C.M., Jones S., and Pratt R.J. A systematic review of the evidence for interventions for the prevention and control of meticillin-resistant Staphylococcus aureus (1996-2004): report to the Joint MRSA Working Party (Subgroup A). J. Hosp. Infect. 63 (2006) S45-S70
25. Mainous A.G., Hueston W.J., Everett C.J., and Diaz V.A. Nasal carriage of Staphylococcus aureus and methicillin-resistant S. aureus in the United States, 2001-2002. Ann. Fam. Med. 4 (2006) 132-137
26. Matsuzaki S., Yasuda M., Nishikawa H., Kuroda M., Ujihara T., Shuin T., et al. Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage phi MR11. J. Infect. Dis. 187 (2003) 613-624
27. O'Flaherty S., Ross R.P., Flynn J., Meaney W.J., Fitzgerald G.F., and Coffey A. Isolation and characterization of two anti-staphylococcal bacteriophages specific for pathogenic Staphylococcus aureus associated with bovine infections. Lett. Appl. Microbiol. 41 (2005) 482-486
28. Pantůček R., Rosypalová A., Doškař J., Kailerová J., Růžičková V., Borecká P., et al. The polyvalent staphylococcal phage φ812: its host-range mutants and related phages. Virology 246 (1998) 241-252
29. Ramesh V., Fralick J.A., and Rolfe R.D. Prevention of Clostridium difficile-induced ileocecitis with bacteriophage. Anaerobe 5 (1999) 69-78
30. Rapson, M.E. (2002) The biology of Staphylococcus aureus-specific bacteriophages and the assessment of their potential as therapeutic agents. PhD thesis, University of Warwick.
31. Rees P.J., and Fry B.A. The morphology of staphylococcal bacteriophage K and DNA metabolism in infected Staphylococcus aureus. J. Gen. Virol. 53 (1981) 293-307
32. Straub M.E., and Applebaum M. Studies on commercial bacteriophage products. J. Am. Med. Assoc. 100 (1933) 110-113
33. Sulakvelidze A., and Barrow P. Phage therapy in animals and agribusiness. In: Kutter E., and Sulakvelidze A. (Eds). Bacteriophages: biology and applications (2005), CRC Press, Boca Raton 335-380
34. Sulakvelidze A., and Kutter E. Bacteriophage therapy in humans. In: Kutter E., and Sulakvelidze A. (Eds). Bacteriophages: biology and applications (2005), CRC Press, Boca Raton 381-436
35. Summers W.C. Bacteriophage therapy. Annu. Rev. Microbiol. 55 (2001) 437-451
36. von Eiff C., Becker K., Machka K., Stammer H., and Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. N. Engl. J. Med. 344 (2001) 11-16
37. Vybiral D., Takac M., Loessner M., Witte A., von Ahsen U., and Blasi U. Complete nucleotide sequence and molecular characterization of two lytic Staphylococcus aureus phages: 44AHJD and P68. FEMS Microbiol. Lett. 219 (2003) 275-283
38. Walker E.S., Vasquez J.E., Bullock H., and Sarubbi F.A. Mupirocin-resistant, methicillin-resistant Staphylococcus aureus: does mupirocin remain effective? Infect. Control Hosp. Epidemiol. 24 (2003) 342-346
39. Wertheim H.F.L., Melles D.C., Vos M.C., van Leeuwen W., van Belkum A., Verbrugh H.A., et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect. Dis. 5 (2005) 751-762
40. Wertheim H.F.L., Vos M.C., Ott A., van Belkum A., Voss A., Kluytmans J., et al. Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet 364 (2004) 703-705
41. Williams R.E.O. Healthy carriage of Staphylococcus aureus: its prevalence and importance. Bacteriol. Rev. 27 (1963) 56-71
42. Wills Q.F., Kerrigan C., and Soothill J.S. Experimental bacteriophage protection against Staphylococcus aureus abscesses in a rabbit model. Antimicrob. Agents Chemother 49 (2005) 1220-1221